These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 34608826)

  • 1. Upregulation of microRNA miR-652-3p is a prognostic risk factor for hepatocellular carcinoma and regulates cell proliferation, migration, and invasion.
    Chi X; Jiang Y; Chen Y; Lv L; Chen J; Yang F; Zhang X; Pan F; Cai Q
    Bioengineered; 2021 Dec; 12(1):7519-7528. PubMed ID: 34608826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-766-3p Inhibits Tumour Progression by Targeting Wnt3a in Hepatocellular Carcinoma.
    You Y; Que K; Zhou Y; Zhang Z; Zhao X; Gong J; Liu Z
    Mol Cells; 2018 Sep; 41(9):830-841. PubMed ID: 30145863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma.
    Li BK; Huang PZ; Qiu JL; Liao YD; Hong J; Yuan YF
    Diagn Pathol; 2014 Dec; 9():226. PubMed ID: 25466449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regulatory effect of lncRNA LINC00943 on the progression of hepatocellular carcinoma and its relationship with clinicopathological features.
    Qi X; Liu L
    Clin Res Hepatol Gastroenterol; 2024 Feb; 48(2):102273. PubMed ID: 38145786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of miR
    Cao Z; Zeng L; Wang Z; Zhou Y; Qian K
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Sept 28; 48(9):1281-1295. PubMed ID: 38044639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of a microRNA panel in diagnosis and prognosis of hepatitis C-associated hepatocellular carcinoma.
    ALrefai AA; Rizk SK; Khamis AK; Kasemy ZA; Habieb MSE
    Lab Med; 2024 May; 55(3):310-319. PubMed ID: 37695165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Extracellular Vesicle-Derived microRNAs as Novel Diagnostic and Prognostic Biomarkers for Non-Viral-Related Hepatocellular Carcinoma.
    Boonkaew B; Satthawiwat N; Pinjaroen N; Chuaypen N; Tangkijvanich P
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-378a-3p as a putative biomarker for hepatocellular carcinoma diagnosis and prognosis: Computational screening with experimental validation.
    Qian F; Wang J; Wang Y; Gao Q; Yan W; Lin Y; Shen L; Xie Y; Jiang X; Shen B
    Clin Transl Med; 2021 Feb; 11(2):e307. PubMed ID: 33634974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-148a-3p suppresses the glycolysis and Cell proliferation by targeting transmembrane protein 54 in liver cancer.
    Yuan X; Wen Y; Shi Q; Zhao Y; Ding J
    Biochem Biophys Res Commun; 2024 Feb; 695():149424. PubMed ID: 38169186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of miR-122 expression after curative resection in patients with hepatocellular carcinoma.
    Ha SY; Yu JI; Choi C; Kang SY; Joh JW; Paik SW; Kim S; Kim M; Park HC; Park CK
    Sci Rep; 2019 Oct; 9(1):14738. PubMed ID: 31611609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-376c-3p Facilitates Human Hepatocellular Carcinoma Progression via Repressing AT-Rich Interaction Domain 2.
    Wang Y; Chang W; Chang W; Chang X; Zhai S; Pan G; Dang S
    J Cancer; 2018; 9(22):4187-4196. PubMed ID: 30519319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-18a promotes hepatocellular carcinoma proliferation, migration, and invasion by targeting Bcl2L10.
    Wang X; Lu J; Cao J; Ma B; Gao C; Qi F
    Onco Targets Ther; 2018; 11():7919-7934. PubMed ID: 30519035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties.
    Coulouarn C; Factor VM; Andersen JB; Durkin ME; Thorgeirsson SS
    Oncogene; 2009 Oct; 28(40):3526-36. PubMed ID: 19617899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [TMEM64 is highly expressed in hepatocellular carcinoma and promotes tumor cell proliferation and invasion].
    Cao D; Cai J; Li Y; Dong R; Wang Z; Zuo X
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Aug; 43(8):1345-1355. PubMed ID: 37712271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic gain/methylation modification/hsa-miR-132-3p increases RRS1 overexpression in liver hepatocellular carcinoma.
    Zhang X; Cong P; Tian L; Zheng Y; Zhang H; Liu Q; Wu T; Zhang Q; Wu H; Huang X; Xiong L
    Cancer Sci; 2023 Nov; 114(11):4329-4342. PubMed ID: 37705317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of LINC01132 in lung cancer and its regulatory role in tumor progression.
    Hu Y; Wei Y
    Discov Oncol; 2024 Feb; 15(1):49. PubMed ID: 38403680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Significance and Functional Insights of Tesmin in Hepatocellular Carcinoma.
    Cao L; Zhang L; Liu S; Wang X
    Genet Res (Camb); 2024; 2024():3058875. PubMed ID: 38283987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-148b-3p Regulates the Expression of DTYMK to Drive Hepatocellular Carcinoma Cell Proliferation and Metastasis.
    He G; Qiu J; Liu C; Tian B; Cai D; Liu S
    Front Oncol; 2021; 11():625566. PubMed ID: 35004265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Meta-Analysis of MiRNA-497 and Prognosis of Hepatocellular Carcinoma.
    Xie Z; Hao Q; Zhu R; Ma R
    Can J Gastroenterol Hepatol; 2024; 2024():2211179. PubMed ID: 38529202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-101-3p-mediated role of PDZK1 in hepatocellular carcinoma progression and the underlying PI3K/Akt signaling mechanism.
    Gao H; Gao Z; Liu X; Sun X; Hu Z; Song Z; Zhang C; Fei J; Wang X
    Cell Div; 2024 Mar; 19(1):9. PubMed ID: 38532426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.